According to the research report titled ‘North America Vascular Graft Market Forecast 2027 By Application, By Raw Material, By End-use, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with MarketStudyReport, North America vascular grafts market size to be worth more than USD 1 billion by the end of forecast timespan 2021-2027.
 

Rising prevalence of chronic kidney diseases, diabetes, and genetic disorders, along with surging demand for hemodialysis are primarily enhancing the North America vascular graft market outlook, claims the study.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4037683/
 

Notably, approximately 750,000 people in United States suffer from kidney failure, every year with an estimated 2 million people suffering worldwide. The demand for dialysis treatment is majorly fueled by chronic renal disease and end-stage renal failures. 
 

Based on application, hemodialysis segment accounted for USD 240.7 million in 2020 and will continue to grow over the analysis period. This can be ascribed to people increasingly opting for vascular grafts as it is their only option for hemodialysis after patients’ superficial veins get depleted as a result continuous dialysis treatment.
 

Meanwhile, endovascular aneurysm repair segment recorded more than USD 295.9 million in 2020 due to growing popularity of minimally invasive surgical procedure. Moreover, it is a cost-effective therapeutic alternative as compared to open surgery for individuals having abdominal aortic aneurysm.
 

With respect to end-users, hospital category held over 62% of the vascular graft market share in North America in 2020 owing to an increasing number of minimally invasive surgical procedures conducted in the hospitals. Additionally, laws aiming to implement high-quality patient care across the region are likely to boost the segmental growth.
 

From a regional perspective, Canada market will develop at a steady y-o-y growth rate of 5.7% as one of three main risk factors for a heart disease – high LDL cholesterol, high blood pressure, and smoking, affects more than 45% of Canadians. The rising prevalence of cardiovascular illness along with diversifying portfolio of firms that are favoring the market growth in North America.
 

For instance, Endologix announced that Alto abdominal stent graft will be implanted for the first time in Canada in May 2021, for abdominal aortic aneurysms patients.
 

Considering the competitive landscape, Cryolife Inc., Endologix Inc., W.L. Gore and Associates Inc., Terumo Corp., Medtronic plc, LeMaitre Vascular Inc., Getinge AB, Cook Medical, B. Braun (B. Braun Melsungen AG), and Becton, Dickinson and Co. are among the major competitors to North America vascular graft market.